Bahramibanan Fatemeh, Taherkhani Amir, Najafi Rezvan, Alizadeh Neda, Ghadimipour Hamidreza, Barati Nastaran, Derakhshandeh Katayoun, Soleimani Meysam
Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Hamadan University of Medical Sciences, Hamadan, I.R. Iran.
Research Center for Molecular Medicine, Institute of Cancer, Avicenna Health Research Institute, Hamadan University of Medical Sciences, Hamadan, I.R. Iran.
Res Pharm Sci. 2025 Feb 20;20(1):121-141. doi: 10.4103/RPS.RPS_128_23. eCollection 2025 Feb.
Colorectal cancer (CRC) holds the position of being the third most prevalent cancer and the second primary cause of cancer-related fatalities on a global scale. Approximately 65% of CRC patients survive for 5 years following diagnosis. Metastasis and recurrence frequently occur in half of CRC patients diagnosed at the late stage. This study used bioinformatics analysis to identify key signaling pathways, hub genes, transcription factors, and protein kinases involved in transforming primary CRC with liver metastasis potential. Prognostic markers in CRC were also identified.
The GSE81582 dataset was re-analyzed to identify differentially expressed genes (DEGs) in early CRC compared to non-tumoral tissues. A protein interaction network (PIN) was constructed, revealing significant modules and hub genes. Prognostic markers, transcription factors, and protein kinases were determined. Boxplot and gene set enrichment analyses were performed.
FINDINGS/RESULTS: This study identified 1113 DEGs in primary CRC compared to healthy controls. PIN analysis revealed 75 hub genes and 8 significant clusters associated with early CRC. The down-regulation of SUCLG2 and KPNA2 correlated with poor prognosis. SIN3A and CDK6 played crucial roles in early CRC transformation, affecting rRNA processing pathways.
This study demonstrated several pathways, biological processes, and genes mediating the malignant transformation of healthy colorectal tissues to primary CRC and may help the prognosis and treatment of patients with early CRC.
结直肠癌(CRC)是全球第三大常见癌症,也是癌症相关死亡的第二大主要原因。大约65%的CRC患者在确诊后存活5年。在晚期确诊的CRC患者中,约半数会频繁发生转移和复发。本研究采用生物信息学分析来确定参与具有肝转移潜能的原发性CRC转化的关键信号通路、枢纽基因、转录因子和蛋白激酶。还确定了CRC中的预后标志物。
重新分析GSE81582数据集,以确定早期CRC与非肿瘤组织相比的差异表达基因(DEG)。构建了蛋白质相互作用网络(PIN),揭示了重要模块和枢纽基因。确定了预后标志物、转录因子和蛋白激酶。进行了箱线图和基因集富集分析。
本研究确定了原发性CRC与健康对照相比有1113个DEG。PIN分析揭示了75个枢纽基因和8个与早期CRC相关的重要簇。SUCLG2和KPNA2的下调与预后不良相关。SIN3A和CDK6在早期CRC转化中起关键作用,影响rRNA加工途径。
本研究证明了几条介导健康结直肠组织向原发性CRC恶性转化的途径、生物学过程和基因,可能有助于早期CRC患者的预后和治疗。